Merck & Company, Inc. NYQ · MRK

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn

GlobeNewswire Inc. · 3d ago

Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates

GlobeNewswire Inc. · 3d ago

Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

GlobeNewswire Inc. · 5d ago

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

GlobeNewswire Inc. · 5d ago

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

The Motley Fool · 9d ago

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

The Motley Fool · 10d ago

The Dividend ETF Quietly Outperforming the S&P 500

The Motley Fool · 11d ago

Moderna Stock Is Soaring. Is It Too Late to Buy?

The Motley Fool · 11d ago

3 Dividend ETF Picks That Could Build Serious Long-Term Wealth

The Motley Fool · 13d ago

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

The Motley Fool · 15d ago

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

The Motley Fool · 15d ago

Big Pharma Has a Case of Merger Mania

The Motley Fool · 18d ago

Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight

GlobeNewswire Inc. · 24d ago

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

GlobeNewswire Inc. · 25d ago

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

GlobeNewswire Inc. · 26d ago

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

The Motley Fool · 28d ago

Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

The Motley Fool · 30d ago

Age-related Macular Degeneration Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 90+ Leading Players Wheeling the Therapeutics Landscape

GlobeNewswire Inc. · 30d ago

FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

Benzinga · 30d ago

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire Inc. · 32d ago

3 Dividend Stocks to Hold for the Long Haul

The Motley Fool · 32d ago

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

GlobeNewswire Inc. · 38d ago

Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial

Benzinga · 39d ago

Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?

The Motley Fool · 40d ago